Patents by Inventor Katsumi Sugiyama
Katsumi Sugiyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240166518Abstract: The carbon nanotube structure in which a plurality of carbon nanotubes are assembled includes a joining portion of end portions of carbon nanotubes and a joining portion of an end portion and a side wall portion of the carbon nanotubes.Type: ApplicationFiled: March 11, 2022Publication date: May 23, 2024Applicants: MITSUBISHI HEAVY INDUSTRIES, LTD., SHINSHU UNIVERSITYInventors: Tomoaki SUGIYAMA, Hidekazu NISHINO, Toshiyasu KIYABU, Katsumi KANEKO
-
Publication number: 20240159902Abstract: A distance measurement device comprises an irradiation unit that irradiates a measurement light onto an object to be measured, a light receiving sensor that receives reflected light from the object to detect an exposure amount based on the reflected light, a memory unit that stores correction information indicating a correction formula set including a plurality of correction formulas and an applicable distance range of each correction formula, and a distance calculation unit that calculates the measurement distance to the object to be measured based on the exposure amount. The distance calculation unit performs, based on the correction information stored in the memory unit, a distance correction calculation to calculate a corrected measured distance by correcting the measured distance using the correction formula corresponding to the applicable distance range in which the measured distance is included among the plurality of correction formulas in the correction formula set.Type: ApplicationFiled: October 10, 2023Publication date: May 16, 2024Inventors: Katsumi ITO, Hisataka SUGIYAMA, Katsuhiko IZUMI
-
Publication number: 20240152350Abstract: A program stop time associated with code adjustment is shortened. A code adjustment device according to a technique disclosed in the present specification of the present application includes a loading unit configured to load an object file that is relocatable, a code adjustment planning unit configured to create a code adjustment plan list using a plurality of elements, each of which is a pair of a position where a code adjustment is to be performed and a corresponding adjustment content in the object file loaded by the loading unit, and, a code adjustment execution unit configured to execute a plurality of code adjustments based on the code adjustment plan list after the code adjustment plan list is created.Type: ApplicationFiled: April 7, 2021Publication date: May 9, 2024Applicant: Mitsubishi Electric CorporationInventors: Katsumi OKUDA, Yoshihiro SUGIYAMA
-
Publication number: 20240132058Abstract: A vehicle system includes a plurality of devices and a controller. The plurality of devices are mounted on the vehicle, and each of the devices implements a function having a safety standard of a predetermined level set therein. The controller is capable of executing processing related to the safety standard on the devices, and includes a plurality of ECUs respectively allocated for the levels of the safety standards. The plurality of ECUs are respectively connected to the devices in which the safety standards of the allocated levels are set without being connected to the devices in which the safety standards of different levels are set, and execute, on the connected devices, processing related to the safety standards according to the allocated levels. Accordingly, the vehicle system can appropriately construct a system that secures safety.Type: ApplicationFiled: January 2, 2024Publication date: April 25, 2024Applicant: Yazaki CorporationInventors: Nobuhiro SUGIYAMA, You Yanagida, Naomi Kisu, Katsumi Sato, Hiromu Ike
-
Publication number: 20090292012Abstract: A therapeutic agent or prophylactic agent for a disease requiring an anti-foaming action for a cell and/or an inhibitory action for acyl-CoA cholesterol acyltransferase in treatment or prevention, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient a processed product derived from Peucedanum japonicum.Type: ApplicationFiled: January 26, 2006Publication date: November 26, 2009Inventors: Tatsuji Enoki, Yoko Kudo, Katsumi Sugiyama, Hiromu Ohnogi, Hiroaki Sagawa, Ikunoshin Kato
-
Patent number: 7498357Abstract: The present invention provides a novel chalcone compound, its derivative or a salt thereof, each having a suppressive action of NO production or an inhibitory action of aldose reductase. In addition, the present invention provides a medicament, a food, a beverage or a feed having a therapeutic or prophylactic effect for a disease showing sensitivity to the compound, by utilizing the physiological actions of the compound.Type: GrantFiled: December 1, 2004Date of Patent: March 3, 2009Assignee: Takara Bio Inc.Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Tatsuji Enoki, Eiji Kobayashi, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20090053383Abstract: According to the present invention, there are provided kneading-free Angelica keiskei tea leaves obtainable by a treatment comprising a step for roast-heating a dried material of Angelica keiskei; an Angelica keiskei tea beverage produced by using the kneading-free Angelica keiskei tea leaves; and a process for producing thereof. The Angelica keiskei tea leaves are preferably heated at a heating temperature of 100° C. to 150° C. in the roast-heating treatment, and the dried material of Angelica keiskei to be subjected to the roast-heating is preferably obtained by drying in a dried system after blanching and has a moisture content of 20% or less. Further, according to the present invention, there is also provided an Angelica keiskei chalcone function-formulated beverage comprising formulated Angelica keiskei chalcones that are components specific to Angelica keiskei.Type: ApplicationFiled: July 18, 2008Publication date: February 26, 2009Applicant: TAKARA BIO INC.Inventors: Hiroshi ENDO, Yasushi Hattori, Hitoshi Sakakibara, Katsumi Sugiyama, Yuko Asai, Satoko Motomura, Ikunoshin Kato
-
Patent number: 7361774Abstract: The present invention relates to a chalcone compound represented by the following general formula: wherein R1 and R2 are taken together with the carbon atom to which they are bound, respectively, to form a hydroxydimethyl hexane ring, or where R1 is a hydroxyl group, R2 is an isohexenyl group, a derivative thereof, or a salt thereof. Also, the present invention relates to a therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, and a food, beverage or feed for treatment or prevention of the above-mentioned disease, characterized in that each comprises the above-mentioned compound as an effective ingredient.Type: GrantFiled: September 29, 2003Date of Patent: April 22, 2008Assignee: Takara Bio Inc.Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Tatsuji Enoki, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20080044498Abstract: The present invention relates to a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an insulin-mimetic action agent, a food, beverage, or feed for treating or preventing a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for enhancement of glucose uptake into a cell, and an agent for induction of an adipocyte differentiation, each comprising as an effective ingredient a processed product derived from a plant belonging to Umbelliferae.Type: ApplicationFiled: October 5, 2007Publication date: February 21, 2008Inventors: Tatsuji Enoki, Kinuko Ogawa, Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20080008773Abstract: The present invention relates to a therapeutic agent or prophylactic agent for a disease requiring promotion of osteogenesis or enhancement of bone morphogenetic protein production, an agent for promotion of osteogenesis or an agent for enhancement of bone morphogenetic protein production, and a food, beverage or feed for promotion of osteogenesis or enhancement of bone morphogenetic protein production, characterized in that each comprises as an effective ingredient a processed product derived from a plant. Also, the present invention relates to a method for measuring an enhancing action for bone morphogenetic protein production, a method for screening a substance having an enhancing action for bone morphogenetic protein production, and a method for preparing a substance having an enhancing action for bone morphogenetic protein production, each method using a specified cell.Type: ApplicationFiled: June 27, 2007Publication date: January 10, 2008Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20070112066Abstract: The present invention provides a novel chalcone compound, its derivative or a salt thereof, each having a suppressive action of NO production or an inhibitory action of aldose reductase. In addition, the present invention provides a medicament, a food, a beverage or a feed having a therapeutic or prophylactic effect for a disease showing sensitivity to the compound, by utilizing the physiological actions of the compound.Type: ApplicationFiled: December 1, 2004Publication date: May 17, 2007Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Tatsuji Enoki, Eiji Kobayashi, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20070092587Abstract: The present invention provides an extract obtainable by extracting a plant belonging to Umbelliferae, or a processed product thereof, with a water-containing alcohol; a process for preparing the extract; a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response and/or diabetic complications, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient the extract as defined above; an agent for an insulin-mimetic action, characterized in that the agent comprises as an effective ingredient the extract as defined above; a food, beverage or feed, comprising the extract as defined above; an agent for enhancing glucose uptake into a cell, characterized in that the agent comprises as an effective ingredient the extract as defined above; to an agent for inducing differentiation into an adipocyte, characterized in that the agent comprises as an effective ingredient the extract as defined above; and an inhibiType: ApplicationFiled: June 18, 2004Publication date: April 26, 2007Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Tatsuji Enoki, Hiroaki Sagawa, Ikunoshin Kato
-
Patent number: 7172261Abstract: A printer includes an ink jet head, a recovery unit, a moving unit, a conveying unit and a cover. The ink jet head performs printing on a printing medium and has an ink ejection port on an ejection port forming surface. The recovery unit is used for a recovery process for maintaining an ink ejection state of the ink jet head in a good condition. The recovery unit includes a cap for covering the ejection port forming surface, a wiping member for wiping the ejection port forming surface, and an absorbing member for receiving ink ejected from the ejection port of the ink jet head. The moving unit moves the recovery unit to a position where the recovery unit faces the ink jet head and to a position where the recovery unit does not face the ink jet head, the ejection forming surface of which is oriented toward the printing medium. The conveying unit conveys the printing medium to be printed by the ink jet head. The cover contains the ink jet head and the recovery unit.Type: GrantFiled: October 26, 2004Date of Patent: February 6, 2007Assignee: Canon Finetech Inc.Inventors: Hitoshi Fujimoto, Katsumi Sugiyama, Masataka Naito, Masatoshi Ikkatai, Tsutomu Harada, Tatsuya Fukushima, Takefumi Tamura, Tsuyoshi Mikoshiba
-
Publication number: 20060051316Abstract: The present invention relates to a therapeutic agent or prophylactic agent for a disease requiring enhancement of bone morphogenetic protein production or promotion of osteogenesis; an agent for enhancement of bone morphogenetic protein production or an agent for promotion of osteogenesis, a food, beverage or feed for enhancement of bone mornhogenetic protein production or promotion of osteogenesis, characterized in that each comprises as an effective ingredient at least one compound selected from the group consisting of (a) an acidic saccharide, (b) a polyacrylic acid, (c) chlorogenic acid and (d) an oxidation processed product of chlorogenic acid, or an extract derived from algae.Type: ApplicationFiled: December 5, 2003Publication date: March 9, 2006Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20060039998Abstract: The present invention relates to a therapeutic agent or prophylactic agent for a disease requiring promotion of osteogenesis or enhancement of bone morphogenetic protein production, an agent for promotion of osteogenesis or an agent for enhancement of bone morphogenetic protein production, and a food, beverage or feed for promotion of osteogenesis or enhancement of bone morphogenetic protein production, characterized in that each comprises as an effective ingredient a processed product derived from a plant. Also, the present invention relates to a method for measuring an enhancing action for bone morphogenetic protein production, a method for screening a substance having an enhancing action for bone morphogenetic protein production, and a method for preparing a substance having an enhancing action for bone morphogenetic protein production, each method using a specified cell.Type: ApplicationFiled: September 29, 2003Publication date: February 23, 2006Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20060034949Abstract: The present invention relates to a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an insulin-mimetic action agent, a food, beverage, or feed for treating or preventing a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for enhancement of glucose uptake into a cell, and an agent for induction of an adipocyte differentiation, each comprising as an effective ingredient a processed product derived from a plant belonging to Umbelliferae.Type: ApplicationFiled: August 6, 2003Publication date: February 16, 2006Inventors: Tatsuji Enoki, Kinuko Ogawa, Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Hiroaki Sagawa, Ikunoshin Kato
-
Patent number: 6979001Abstract: A wheel bearing includes a sealing device 5 positioned between inner and outer members 1 and 2. This sealing device 5 includes an elastic member 14, which eventually forms an encoder grid and is provided on a first annular sealing plate 11. A second annular sealing plate 12 is provided with sealing lips 16a to 16c. An engagement 18 between a cylindrical wall 11a of the first annular sealing plate 11 and the inner member 1 is provided with an elastic member 20 made of a material dissimilar to that for the elastic material 14. This elastic member 20 may be a rubber coated layer, resin paint layer, a thin film of adhesive material or a ring-shaped rubber member. Thereby, any possible ingress of water across an engagement surface of the annular sealing plate is prevented, accompanied by increase of the lifetime of the bearing, with no problem associated with separation and displacement of the annular sealing plates. The magnetic flux density can also be easily secured.Type: GrantFiled: June 27, 2003Date of Patent: December 27, 2005Assignee: NTN CorporationInventors: Hisashi Ohtsuki, Takayuki Norimatsu, Eiji Funahashi, Koji Kametaka, Motoharu Niki, Katsumi Sugiyama, Kenro Adachi
-
Publication number: 20050272809Abstract: The present invention relates to a novel chalcone compound represented by the following general formula: wherein R1 and R2 are taken together with the carbon atom to which they are bound, respectively, to form a hydroxydimethyl hexane ring, or where R1 is a hydroxyl group, R2 is an isohexenyl group, a derivative thereof, or a salt thereof. Also, the present invention relates to a therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, and a food, beverage or feed for treatment or prevention of the above-mentioned disease, characterized in that each comprises the above-mentioned compound as an effective ingredient.Type: ApplicationFiled: September 29, 2003Publication date: December 8, 2005Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Nobuko Muraki, Tatsuji Enoki, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20050250715Abstract: The present invention relates to a therapeutic agent or prophylactic agent for a disease requiring enhancement of nerve growth factor (NGF) production upon treatment or prevention, an enhancing agent for nerve growth factor production, and a food, beverage or feed for enhancing nerve growth factor production, characterized in that each comprises as an effective ingredient a compound selected from the group consisting of soyasaponin compounds, soyasapogenin compounds, glycyrrhizin and salts thereof. In addition, the present invention relates to a novel soyasaponin compound and a novel soyasapogenin compound, having an action for enhancement of NGF production.Type: ApplicationFiled: July 17, 2003Publication date: November 10, 2005Inventors: Hiromu Ohnogi, Katsumi Sugiyama, Hiroaki Sagawa, Ikunoshin Kato
-
Publication number: 20050088481Abstract: A printer includes an ink jet head, a recovery unit, a moving unit, a conveying unit and a cover. The ink jet head performs printing on a printing medium and has an ink ejection port on an ejection port forming surface. The recovery unit is used for a recovery process for maintaining an ink ejection state of the ink jet head in a good condition. The recovery unit includes a cap for covering the ejection port forming surface, a wiping member for wiping the ejection port forming surface, and an absorbing member for receiving ink ejected from the ejection port of the ink jet head. The moving unit moves the recovery unit to a position where the recovery unit faces the ink jet head and to a position where the recovery unit does not face the ink jet head, the ejection forming surface of which is oriented toward the printing medium. The conveying unit conveys the printing medium to be printed by the ink jet head. The cover contains the ink jet head and the recovery unit.Type: ApplicationFiled: October 26, 2004Publication date: April 28, 2005Applicant: Canon Finetech Inc.Inventors: Hitoshi Fujimoto, Katsumi Sugiyama, Masataka Naito, Masatoshi Ikkatai, Tsutomu Harada, Tatsuya Fukushima, Takefumi Tamura, Tsuyoshi Mikoshiba